Safety and efficacy of lumiracoxib compared with NSAIDs.
Rosenberg
Jonathan A
JA
Department of Medicine, University of Illinois at Chicago, 60612, USA.
Goldstein
Jay L
JL
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000139:chemically induced* / Q000453:epidemiology; D004008:Diclofenac / Q000031:analogs & derivatives; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D005767:Gastrointestinal Diseases / Q000139:chemically induced* / Q000453:epidemiology; D006801:Humans; D015994:Incidence; D009930:Organic Chemicals / Q000009:adverse effects / Q000627:therapeutic use*; D010003:Osteoarthritis / Q000188:drug therapy*; D012307:Risk Factors; D013997:Time Factors; D016896:Treatment Outcome
D000894:Anti-Inflammatory Agents, Non-Steroidal; D009930:Organic Chemicals; D004008:Diclofenac; C473384:lumiracoxib